WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006114260) PHENYLACETYLENE DERIVATIVES HAVING MGLUR5 RECEPTOR AFFINITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/114260    International Application No.:    PCT/EP2006/003764
Publication Date: 02.11.2006 International Filing Date: 24.04.2006
IPC:
C07C 211/52 (2006.01), C07D 277/42 (2006.01), C07D 231/38 (2006.01), C07D 213/74 (2006.01), C07D 241/42 (2006.01), C07D 241/44 (2006.01), C07D 215/40 (2006.01), C07D 487/04 (2006.01), C07D 231/56 (2006.01), C07D 285/14 (2006.01), C07D 405/04 (2006.01), C07D 239/12 (2006.01), C07D 241/20 (2006.01), C07D 233/54 (2006.01), C07D 235/06 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4002 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW only).
NOVARTIS PHARMA GmbH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
GLATTHAR, Ralf [DE/DE]; (DE) (For US Only).
TROXLER, Thomas, J. [CH/CH]; (CH) (For US Only)
Inventors: GLATTHAR, Ralf; (DE).
TROXLER, Thomas, J.; (CH)
Agent: GRIMM, Siegfried; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
0508318.3 25.04.2005 GB
Title (EN) PHENYLACETYLENE DERIVATIVES HAVING MGLUR5 RECEPTOR AFFINITY
(FR) DERIVES DE PHENYLACETYLENE POSSEDANT UNE AFFINITE POUR LE RECEPTEUR MGLUR5
Abstract: front page image
(EN)The invention provides compounds of formula (I) wherein the substituents are as defined in the specification, to processes for their preparation and corresponding intermediates, and their use as modulators of the mglu5 receptor.
(FR)L'invention concerne des composés de formule (I), les substituants étant définis dans la spécification, des procédés de préparation de ceux-ci et des intermédiaires correspondants, ainsi que l'utilisation de ceux-ci comme modulateurs du récepteur mglu5.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)